High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib
Al-Ali, Haifa-Kathrin, Heinrich, Michael Charles, Lange, Thoralf, Krahl, Rainer, Mueller, Matthias, Müller, Christel, Niederwieser, Dietger, Druker, Brian James, Deininger, Michael Werner NikolausVolume:
5
Year:
2004
Language:
english
Journal:
The Hematology Journal
DOI:
10.1038/sj.thj.6200319
File:
PDF, 122 KB
english, 2004